CC1CCCN(c2nc(N(C)c3ccccc3)nc(N)c2[N+](=O)[O-])C1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?